Skip to main content
Nova Agritech Limited logo

Nova Agritech Limited — Investor Relations & Filings

Ticker · NOVAAGRI ISIN · INE02H701025 LEI · 894500GK6PSFQO5I1974 BSE.NS Manufacturing
Open in API
Filings indexed 150 across all filing types
Latest filing 2025-08-11 Regulatory Filings
Country IN India
Listing BSE.NS NOVAAGRI

About Nova Agritech Limited

https://novaagri.in

Nova Agritech Limited specializes in the manufacturing and distribution of a comprehensive range of agricultural input products. The company's portfolio encompasses soil health management solutions, crop nutrition products, bio-stimulants, bio-pesticides, and Integrated Pest Management (IPM) tools. It focuses on enhancing agricultural productivity through research-driven formulations, including micronutrients, organic fertilizers, and plant growth regulators. By providing technologically advanced inputs, the company aims to improve soil fertility and crop yields while promoting sustainable farming practices. Its operations involve extensive field trials and farmer outreach programs to ensure the effective application of its diverse product line across various climatic zones and crop types.

Recent filings

Filing Released Lang Actions
Monitoring Agency Report
Regulatory Filings Classification · 95% confidence The document is a Monitoring Agency Report related to the utilization of IPO proceeds for the quarter ended June 30, 2025. It references SEBI regulations specifically related to issue of capital and disclosure requirements, and includes detailed information on the use of funds raised through the IPO. The report is issued by CARE Ratings Limited, the appointed monitoring agency, and includes certifications and comments on the utilization of proceeds. This type of report is a regulatory compliance document that monitors the use of IPO funds, which is distinct from financial performance reports or earnings releases. It is not an Annual Report, Interim Report, or Earnings Release. It is also not a simple announcement or certification but a substantive report on IPO proceeds utilization. Therefore, the most appropriate classification is a Regulatory Filing (RNS), as it is a regulatory compliance report that does not fit into other specific categories like Annual Report or Earnings Release.
2025-08-11 English
General Updates
AGM Information Classification · 95% confidence The document is an official communication dated 9th August 2025 from Nova Agritech Limited to stock exchanges regarding the intimation of the 18th Annual General Meeting (AGM) and the calendar of events related to the AGM. It includes details such as the date of the AGM, cut-off dates for voting, dispatch of notice, e-voting start and end dates, and appointment of the scrutinizer and authorized agency for e-voting. The document does not contain the AGM notice itself or the full AGM materials but is an announcement about the scheduling and procedural details of the AGM. The document length is 3289 characters, which is relatively short and consistent with an announcement rather than a full report or presentation. Therefore, this document fits the category of AGM Information (AGM-R) as it relates to the AGM event and its procedural details.
2025-08-09 English
Change in Director(s)
Board/Management Information Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the re-appointment of a director, Mr. Kiran Kumar Adapa, for a second term. It references compliance with SEBI regulations and includes details about the director's profile and terms of appointment. There are no financial statements, earnings data, or detailed management discussion. The document is an announcement of a board/management change, specifically the re-appointment of a director, which fits the category of Board/Management Information (MANG). The document length is 4161 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2025-08-09 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the statement of deviation or variation in the utilization of IPO proceeds. It references Regulation 32 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which mandates disclosure of any deviation in the use of IPO funds. The document confirms that there is no deviation or variation in the utilization of IPO proceeds and includes details about the IPO, monitoring agency, and audit committee review. The document length is 3679 characters, which is relatively short and primarily serves as a regulatory compliance disclosure rather than a full financial report or detailed analysis. It is not an annual report, interim report, earnings release, or any other detailed financial filing. It is a regulatory announcement related to IPO proceeds utilization, fitting best under Regulatory Filings (RNS) as it does not contain comprehensive financial statements or detailed financial data but is a compliance disclosure.
2025-08-09 English
Outcome of Board Meeting
Regulatory Filings
2025-08-09 English
Outcome of Board Meeting
Regulatory Filings
2025-08-09 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.